Kyverna Therapeutics (KYTX) Interest & Investment Income (2023 - 2026)
Kyverna Therapeutics' (KYTX) quarterly Interest & Investment Income came in at $2.3 million in Q1 2026, down 17.63% YoY from $2.8 million in Q1 2025, and up 22.15% on a QoQ basis from $1.9 million in Q4 2025.
Kyverna Therapeutics (KYTX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Kyverna Therapeutics (KYTX) has 4 years of Interest & Investment Income data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Interest & Investment Income fell 17.63% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 44.36% YoY) and the FY2025 annual result came in at $9.1 million, down 40.79% from the prior year.
- Interest & Investment Income advanced to $2.3 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.7 million in Q2 2024 to a low of $264000.0 in Q2 2023.
- A 4-year average of $2.2 million and a median of $2.3 million in 2026 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2024 — Interest & Investment Income soared 1678.03% — and 2025, when it plunged 54.08%.
- Tracing KYTX's Interest & Investment Income over 4 years: stood at $789000.0 in 2023, then jumped by 353.11% to $3.6 million in 2024, then sank by 46.71% to $1.9 million in 2025, then grew by 22.15% to $2.3 million in 2026.
- The last three Interest & Investment Income figures came in at $2.3 million (Q1 2026), $1.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Kyverna Therapeutics | 505.26 Mn | 505.26 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 4.69 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 789,000.00 |
| Sep 30, 2023 | 880,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | 349,000.00 |